Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa
Domain:
healthcareRecord type:
paper
Creator:
EvaEvaTiv
Publisher:
MDP
Host:
As part of a multinational study to evaluate the Bioline Hepatitis C virus (HCV) point-of-care (POC) testing in sub-Saharan Africa (SSA), this narrative review summarises regulatory standards and quality indicators for validating and approving HCV clinical diagnostics. In addition, this review also provides a summary of their diagnostic evaluations using the REASSURED criteria as the benchmark and its implications on the WHO HCV elimination goals 2030.
Similar
Hepatitis C virus diversity in sub-Saharan Africa and implications for treatment with Direct Acting AntiviralsRisk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan AfricaPoint-of-Care Diagnostics for Improving Maternal Health in South AfricaSystematic Review and Meta-Analysis of the Diagnostic Accuracy of Mobile-Linked Point-of-Care Diagnostics in Sub-Saharan AfricaGenotyping of hepatitis C virus in South AfricaTowards a culture of quality assurance in optometric education in sub-Saharan Africa